Autologous incubated macrophage therapy in acute, complete spinal cord injury: Results of the phase 2 randomized controlled multicenter trial

Spinal Cord

Volumn 50, Issue 9, 2012, Pages 661-671

  Lammertse, D P ^a,b   Jones, L A T ^c   Charlifue, S B ^a   Kirshblum, S C ^d,e   Apple, D F ^f   Ragnarsson, K T ^g   Falci, S P ^a   Heary, R F ^h   Choudhri, T F ⁱ   Jenkins, A L ⁱ   Betz, R R ^j   Poonian, D ^k   Cuthbert, J P ^a   Jha, A ^a,b   Snyder, D A ^l   Knoller, N ^m  

^a CRAIG HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c SCI Clinical Trial Consultant   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e KESSLER INSTITUTE FOR REHABILITATION   (United States)

^f SHEPHERD CENTER   (United States)

^g MOUNT SINAI MEDICAL CENTER   (United States)

^h UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j SHRINERS HOSPITALS FOR CHILDREN   (United States)

^k DP Clinical   (United States)

^l Gamida Cell Ltd Cell Therapy Technologies   (Israel)

^m SHEBA MEDICAL CENTER   (Israel)

more..

Author keywords

acute spinal cord injury; cellular therapy; macrophage; neurological recovery

Indexed keywords

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADOLESCENT; ADULT; ANEMIA; ANTIBIOTIC THERAPY; ANXIETY DISORDER; ARTHRALGIA; ARTICLE; ATELECTASIS; AUTOLOGOUS INCUBATED MACROPHAGE THERAPY; AUTOTRANSPLANTATION; BACTERIAL MENINGITIS; BLADDER AND BOWEL MANAGEMENT; BLADDER STONE; BODY MASS; CELLULITIS; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DECUBITUS; DEEP VEIN THROMBOSIS; DEHYDRATION; DEPRESSION; DIARRHEA; DISEASE COURSE; DYSAUTONOMIA; FECES INCONTINENCE; FEMALE; FEVER; FOLLOW UP; HEADACHE; HETEROTOPIC OSSIFICATION; HUMAN; HYPERTRANSAMINASEMIA; HYPOALBUMINEMIA; HYPOKALEMIA; IMMUNOTHERAPY; INSOMNIA; MALE; MULTICENTER STUDY; MUSCULOSKELETAL PAIN; MYCOSIS; NAUSEA; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PATIENT SAFETY; PERIPHERAL EDEMA; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; PROSTHESIS FAILURE; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; SPASTICITY; SPINAL CORD INJURY; SPINAL PAIN; SPINE INSTABILITY; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

ACUTE DISEASE; ADOLESCENT; ADULT; FEMALE; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; SPINAL CORD INJURIES; TISSUE THERAPY; TRANSPLANTATION, AUTOLOGOUS; TREATMENT FAILURE; YOUNG ADULT;

EID: 84866512164     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2012.39     Document Type: Article

References (22)

1. American Association of Neurological Surgeons/Congress of Neurological Surgeons. Pharmacological therapy after acute cervical spinal cord injury. Neurosurgery 2002; 50: S63-S72.
2. Rasouli A, Lammertse DP, Wang MY. A review of clinical trials and future directions for clinical studies in acute spinal cord injury. In: Lin VW (ed.) Spinal Cord Medicine: Principles and Practice, 2nd edn. Demos Medical: New York, 2010, pp 922-929.
3. Hawryluk GW, Rowland J, Kwon BK, Fehlings MG. Protection and repair of the injured spinal cord: A review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg Focus 2008; 5: 1-16.
4. Perry VH, Brown MC, Gordon S. The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. J Exper Med 1987; 165: 1218-1223.
5. Zeev-Brann AB, Lazarov-Spiegler O, Brenner T, Schwartz M. Differential effects of central and peripheral nerves on macrophages an microglia. Glia 1998; 23: 181-190.
6. Lazarov-Spiegler O, Solomon AS, Schwartz M. Peripheral nerve-stimulated macrophages simulate a peripheral nerve-like regenerative response in rat transected optic nerve. Glia 1998; 24: 329-337.
7. Rapalino O, Lazarov-Spiegler O, Agranov E, Velan GJ, Yoles E, Fraidakis M et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 1998; 4: 814-821.
8. Bromstein Y, Marder JB, Vitner K, Smirnov I, Lisaey G, Butovsky O et al. Features of skin-coincubated macrophages that promote recovery from spinal cord injury. J Neuroimmunol 2003; 142: 10-16.
9. Knoller N, Auerbach G, Fulga V, Zelig G, Attias J, Bakimer R et al. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: Phase I study results. J Neurosurg Spine 2005; 3: 173-181.
10. Jones LAT, Lammertse DP, Charlifue SB, Kirshblum SC, Apple DF, Ragnarsson KT et al. A phase 2 autologous cellular therapy trial in patients with acute, complete spinal cord injury: Pragmatics, recruitment, and demographics. Spinal Cord 2010; 48: 798-807.
11. American Spinal Injury Association. International Standards for Neurological Classification of Spinal Cord Injury. revised 2000, reprinted 2002 American Spinal Injury Association Chicago, IL, 2002.
12. Consortium for Spinal Cord Medicine. Outcomes Following Traumatic Spinal Cord Injury: Clinical Practice Guidelines for Health-care Professionals. Paralyzed Veterans of America: Washington, DC, 1999.
13. Marino RJ, Jones L, Kirshblum S, Tal J, Dasgupta A. Reliability and repeatability of the motor and sensory examination of the International Standards for Neurological Classification of Spinal Cord Injury. J Spinal Cord Med 2008; 31: 166-170.
14. Fawcett JW, Curt A, Steeves JD, Coleman WP, Tuszynski MH, Lammertse DP et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: Spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 2007; 45: 190-205.
15. Spiess M, Mü ller RM, Rupp R, Schuld C. van Hedel HJA. Conversion in ASIA impairment scale during the first year after traumatic spinal cord injury. J Neurotrauma 2009; 26: 2027-2036.
16. Steeves JD, Lammertse D, Curt A, Fawcett JW, Tuszynski MH, Ditunno JF et al. Guidelines for the conduct of clinical trials in spinal cord injury as developed by the ICCP panel: Clinical trial outcome measures. Spinal Cord 2007; 45: 206-221.
17. Rajan S, McNeely MJ, Warms C, Goldstein B. Clinical assessment and management of obesity in individuals with spinal cord injury: A review. J Spinal Cord Med 2008; 31: 361-372.
18. Choban PS, Flancbaum L. The impact of obesity on surgical outcomes: A review. J Am Coll Surg 1997; 185: 593-603.
19. Patel N, Bagan B, Vadera S, Maltenfort MG, Deutsch H, Vaccaro AR et al. Obesity and spine surgery: Relation to perioperative complications. J Neurosurg Spine 2007; 6: 291-297.
20. Shechter R, London A, Varol C, Raposo C, Cusimano M, Yovel G et al. Infiltrating bloodderived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 2009; 6: E1000113.
21. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neuroscience 2009; 29: 13435-13444.
22. Schwartz M. 'Tissue-repairing' blood-derived macrophages are essential for healing of the injured spinal cord: from skin-activated macrophages to infiltrating blood-derived cells? Brain Behav Immun 2010; 24: 1054-1057.